The anti‐cancer effect of epigallocatechin‐3‐O‐gallate against multiple myeloma cells is potentiated by 5,7‐dimethoxyflavone
Open Access
- 25 September 2023
- journal article
- research article
- Published by Wiley in FEBS Open Bio
- Vol. 13 (11) , 2147-2156
Abstract
(−)‐Epigallocatechin‐3‐O‐gallate (EGCG) is one of the major components of green tea polyphenol. Previous studies have shown that EGCG induces cancer‐specific cell death in vitro and in vivo without causing severe side effects. However, the anti‐cancer effect of EGCG alone is limited. 5,7‐dimethoxyflavone (5,7‐DMF), one of the principal functional components of black ginger (Kaempferia parviflora), also exerts anti‐cancer effects. Here, we show that 5,7‐DMF synergistically enhances the anti‐cancer effect of EGCG in multiple myeloma cells by potentiating EGCG‐induced intracellular cyclic guanosine monophosphate (cGMP) production. Moreover, the combination of EGCG and 5,7‐DMF induces apoptotic cell death in multiple myeloma cells, and this is accompanied by activation of the cGMP/acid sphingomyelinase (ASM)/cleaved caspase‐3 pathway. In conclusion, we have shown that 5,7‐DMF enhances the anti‐cancer effect of EGCG by upregulating cGMP in multiple myeloma cells.Keywords
Funding Information
- Japan Society for the Promotion of Science (15H02448, JP20H05683)
- National Research Foundation of Korea (NRF‐2021R1C1C2095006)
This publication has 32 references indexed in Scilit:
- 67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosisJournal of Clinical Investigation, 2013
- Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developmentsBritish Journal of Pharmacology, 2012
- Ceramide synthases at the centre of sphingolipid metabolism and biologyBiochemical Journal, 2012
- Epigallocatechin‐3‐gallate induces cell death in acute myeloid leukaemia cells and supports all‐trans retinoic acid‐induced neutrophil differentiation via death‐associated protein kinase 2British Journal of Haematology, 2010
- Phase I Trial of Daily Oral Polyphenon E in Patients With Asymptomatic Rai Stage 0 to II Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2009
- Green Tea Consumption and Hematologic Malignancies in Japan: The Ohsaki StudyAmerican Journal of Epidemiology, 2009
- Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implicationsBlood, 2006
- Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agentsPharmacology & Therapeutics, 2006
- Dynamic Association of Nitric Oxide Downstream Signaling Molecules with Endothelial Caveolin-1 in Rat AortaThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Soluble Guanylyl Cyclase and Platelet FunctionaAnnals of the New York Academy of Sciences, 1994